PODD Stock Cash Flow Statements

Insulet Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Insulet Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31

cash flows from operating activities
net income	22,500,000	35,400,000	100,700,000	77,500,000	188,600,000	51,500,000	103,300,000	51,900,000	27,300,000	23,800,000	17,000,000	-5,200,000	-35,000,000	27,800,000	29,200,000	12,600,000			-17,100,000	11,600,000	14,400,000	-2,100,000	4,968,000	852,000	1,402,000	4,378,000	9,893,000	1,659,000	-1,691,000	-6,569,000	-6,860,000	-2,227,000	-7,767,000	-9,977,000	-9,119,000	-3,081,000	-4,198,000	-12,481,000	-27,327,000	-18,927,000	-15,432,000	-11,834,000	-5,400,000	-10,845,000	-29,111,000	-6,144,000	-2,500,000	-21,290,000	-10,519,000	-10,665,000	-10,194,000	-12,417,000	-14,476,000	-14,780,000	-14,339,000	-13,562,000	-19,421,000	-9,848,000	-20,858,000	-12,100,000	-14,346,000	-13,855,000	-14,932,000	-24,725,000	-20,239,000	-19,645,000	-28,283,000	-20,752,000	-23,882,000	-19,874,000	-15,668,000	-13,639,000	-12,672,000	-11,560,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	22,300,000	21,700,000	21,500,000	21,300,000	19,200,000	18,800,000	18,800,000	18,700,000	18,100,000	17,200,000	16,200,000	15,900,000	15,800,000	15,300,000	14,900,000	14,500,000	15,200,000	12,800,000	25,700,000	10,900,000	9,900,000	8,900,000	9,116,000	7,758,000	5,891,000	5,135,000	4,392,000	4,123,000	3,609,000	3,522,000	3,321,000	3,826,000	3,384,000	3,323,000	3,359,000	3,629,000	3,423,000	3,422,000	4,432,000	4,292,000	3,681,000	3,433,000	3,055,000	3,068,000	3,030,000	3,070,000	2,947,000	3,096,000	2,859,000	2,904,000	2,938,000	2,594,000	2,654,000	2,844,000	2,820,000	2,836,000
stock-based compensation expense	7,500,000	18,200,000	20,000,000	18,100,000	17,000,000	14,200,000	12,600,000	10,500,000	13,100,000	12,100,000	11,200,000	9,000,000	11,200,000	9,500,000		8,200,000	9,000,000	8,600,000					7,996,000	6,626,000	8,294,000	5,784,000	6,316,000	16,088,000	6,936,000	8,181,000	8,390,000	8,896,000	7,531,000	7,124,000	6,767,000	6,066,000	5,513,000	5,271,000	5,326,000	4,222,000	4,325,000	5,305,000	4,272,000	9,670,000	4,217,000	4,360,000	2,883,000	2,956,000	3,849,000	2,995,000	2,420,000	2,345,000	2,546,000	2,609,000	2,128,000	1,790,000	1,855,000	1,961,000
non-cash interest expense	2,100,000	2,500,000	1,900,000	1,600,000	1,800,000	2,000,000	2,100,000	1,600,000	1,500,000	1,500,000	1,500,000	1,500,000	1,300,000	1,500,000		8,400,000							11,326,000	8,902,000	7,749,000	7,623,000	7,492,000	7,363,000	7,264,000	7,163,000																				2,908,000	2,656,000	2,568,000	2,536,000	2,452,000												121,000
loss on extinguishment of debt	84,400,000	39,500,000														1,500,000																												4,260,000
deferred income taxes			3,900,000	-1,600,000
benefit from credit losses	300,000	4,800,000	-800,000	0	-600,000	1,200,000	200,000	100,000	800,000	1,200,000	1,100,000	1,200,000	1,100,000	800,000	300,000	700,000	200,000	1,900,000	200,000	500,000	2,000,000	600,000
other	-2,700,000	6,700,000	-200,000	600,000	4,400,000	100,000	100,000	-1,200,000	300,000	700,000	1,700,000	100,000	1,600,000	-600,000	1,000,000	-900,000	-1,000,000	2,100,000	500,000			800,000	-750,000	2,439,000	-263,000	-326,000		-105,000	-176,000	46,000		145,000				7,000	-7,000	139,000
changes in operating assets and liabilities:
accounts receivable	-14,600,000	-27,200,000	3,600,000	-9,300,000	-14,700,000	3,500,000	-47,300,000	-25,000,000	-7,900,000	-19,200,000	15,400,000	-3,600,000	-4,800,000	-19,900,000	-35,800,000	-16,000,000	-2,200,000	-17,300,000	4,300,000	-6,100,000	800,000	-14,600,000									-6,565,000	-10,127,000	2,516,000	-12,146,000	9,557,000	-678,000	1,366,000	2,306,000	-15,079,000	-1,590,000	3,415,000	3,461,000	6,678,000	-6,213,000	-6,031,000	-4,503,000	599,000	-2,189,000	-3,781,000	857,000	-4,237,000	-5,389,000	19,000	-3,906,000	-7,419,000	2,741,000	-404,000	1,465,000	-2,197,000	-476,000	-1,196,000	-1,327,000	267,000	-1,998,000	-2,650,000	-2,591,000	-2,348,000	-2,972,000	-3,087,000	-3,012,000	-1,878,000	-1,003,000	-784,000	-821,000
accounts receivable — related party	-18,900,000	-6,200,000	900,000	-14,300,000	-13,200,000	33,100,000	-39,600,000	3,000,000	-25,300,000	7,100,000	-16,400,000	4,200,000	-16,600,000	-10,100,000
inventories	1,900,000	-6,600,000	6,200,000	-8,300,000	-700,000	-29,600,000	11,700,000	-2,600,000	-24,500,000	-38,200,000	-14,600,000	-10,500,000	-11,000,000	-13,000,000	-46,300,000	-63,100,000	-27,100,000	-17,900,000	-27,600,000	-20,100,000	-7,600,000	4,800,000	-10,154,000	-6,041,000	-11,315,000	-2,690,000	-13,547,000	-17,320,000	-14,665,000	6,706,000	1,261,000	-1,099,000	352,000	1,175,000	-2,816,000	-8,188,000	-10,450,000	-2,649,000	-1,034,000	10,648,000	-3,370,000	-6,966,000	-3,437,000	-897,000	1,684,000	-985,000	-4,069,000	584,000	3,220,000	5,668,000	222,000	1,337,000	-1,723,000	-2,865,000	1,285,000	2,785,000	-1,421,000	-770,000
prepaid expenses and other assets	-18,800,000	-12,800,000	-5,100,000	-1,100,000	-15,300,000	-400,000	-17,600,000	-4,700,000	900,000	-20,700,000	-4,700,000	-8,800,000	-16,900,000	-6,400,000	-14,000,000	-2,700,000	-15,900,000	-14,100,000	-15,400,000	-2,800,000	-14,700,000	700,000	-17,017,000	-1,807,000	2,487,000	-5,563,000	-6,343,000	-435,000	-1,499,000	-3,324,000	-2,038,000	372,000	-241,000	-1,421,000	647,000	-1,063,000	-1,743,000	-462,000	-1,502,000	-590,000	248,000	384,000	-580,000	2,248,000	-102,000	-904,000	1,081,000	654,000	-152,000	-1,903,000	1,068,000	-1,241,000	4,000	-729,000
accounts payable	36,100,000	36,500,000	-17,800,000	-36,400,000	900,000	55,500,000	-52,500,000	-33,000,000	23,000,000	51,500,000	-25,700,000	3,200,000	5,400,000	14,700,000	-21,600,000	10,400,000	-9,400,000	5,000,000
accrued expenses and other liabilities	68,500,000	-48,800,000	21,600,000	43,200,000	51,000,000	-62,400,000	57,600,000	35,900,000	16,200,000	-35,900,000	46,100,000	49,600,000	71,900,000	-33,700,000	29,100,000	600,000	22,700,000	-28,000,000
accrued expenses and other liabilities — related party	-1,100,000	100,000	-8,700,000	3,400,000	-2,700,000	100,000	-4,200,000	800,000	500,000	-600,000	1,900,000	100,000	1,300,000	400,000
net cash from operating activities	196,500,000	63,800,000	147,700,000	98,500,000	96,500,000	87,600,000	45,200,000	56,000,000	44,000,000	500,000	50,700,000	56,700,000	25,300,000	-13,700,000	-25,500,000	-25,800,000	18,300,000	-35,100,000	-1,000,000	62,200,000	26,400,000	-3,600,000	46,933,000	31,190,000	13,910,000	6,367,000	30,439,000	15,855,000	-6,129,000	-4,266,000	21,800,000	23,278,000	17,964,000	-21,835,000	20,070,000	2,677,000	3,681,000	-10,517,000			785,000	-3,488,000	4,607,000	4,822,000	508,000	-1,017,000	-3,518,000	3,694,000	4,372,000	-1,200,000	-5,593,000	-3,449,000	-11,114,000	-8,903,000	-7,668,000	-836,000	-9,082,000	-7,866,000	-7,703,000	-12,864,000	-5,880,000	-9,178,000	-9,858,000	-11,002,000	-15,492,000	-12,971,000	-16,976,000	-23,423,000	-28,101,000	-14,111,000	-16,208,000	-12,765,000	-9,534,000	-11,865,000
cash flows from investing activities
capital expenditures	-18,600,000	-12,300,000	-53,600,000	-26,700,000	-22,500,000	-22,100,000	-29,300,000	-20,100,000	-15,700,000	-10,500,000	-64,400,000	-31,100,000	-14,600,000	-12,800,000	-31,800,000	-27,300,000	-19,900,000	-32,900,000	-40,500,000	-36,800,000	-24,800,000	-26,900,000	-49,115,000
free cash flows	177,900,000	51,500,000	94,100,000	71,800,000	74,000,000	65,500,000	15,900,000	35,900,000	28,300,000	-10,000,000	-13,700,000	25,600,000	10,700,000	-26,500,000	-57,300,000	-53,100,000	-1,600,000	-68,000,000	-41,500,000	25,400,000	1,600,000	-30,500,000	-2,182,000
investments in developed software	-4,600,000	-3,400,000	-2,400,000	-2,400,000	-2,400,000	-1,900,000	-2,300,000	-2,300,000	-2,400,000	-1,500,000
net cash from investing activities	-23,200,000	-15,700,000	-68,000,000	-29,300,000	-24,900,000	-24,000,000	-31,600,000	-22,600,000	-23,100,000	-42,100,000	-88,400,000	-33,900,000	-21,900,000	-46,900,000	-36,400,000	-12,200,000	-11,400,000	-22,700,000	-51,300,000	-15,300,000	67,200,000	13,400,000	-53,996,000	12,189,000	-39,413,000	7,620,000	-40,785,000	-26,616,000	-61,115,000	-55,988,000	-149,312,000	2,781,000	-21,980,000	-42,286,000	-97,183,000	-45,039,000	-37,242,000	1,454,000	-3,482,000	-7,240,000	-255,000	-4,346,000	-2,633,000	-3,108,000	-3,588,000	-2,157,000	-2,790,000	-1,822,000	-1,626,000	-1,069,000	-2,055,000	-4,687,000	-2,550,000	-1,699,000	-2,276,000	-3,278,000	-40,518,000	-2,897,000	-2,917,000	-1,646,000	-896,000	-1,090,000	-1,172,000	-1,212,000	-591,000	-165,000	-606,000	-1,617,000	-2,545,000	-5,279,000	-1,749,000	-2,830,000	-3,179,000	-2,331,000
cash flows from financing activities
proceeds from issuance of senior unsecured notes, net of issuance costs	0	440,700,000
repayment of convertible debt	-377,600,000	-163,900,000													-100,000	0							-209,992,000
settlement of capped call options	52,600,000	23,100,000
proceeds from issuance of term loan b, net of issuance costs
repayment of term loan b	-16,700,000	-1,300,000
repayment of equipment financings	-3,600,000	-3,500,000	-3,500,000	-3,300,000	-5,000,000	-7,200,000	-5,000,000	-4,900,000	-5,100,000	-4,800,000	-4,400,000	-4,400,000	-4,300,000	-4,300,000	-8,200,000	-3,200,000	-3,200,000	-3,200,000
financing lease payments
repayment of mortgage	-600,000	-600,000	-600,000	-600,000	-600,000	-600,000	-500,000	-600,000	-500,000	-600,000	-500,000	-500,000	-600,000	-500,000	-500,000	-500,000	-400,000	-600,000
proceeds from secured borrowing	20,700,000	15,400,000	12,900,000
repayment of secured borrowing	-19,200,000	-13,400,000	-17,600,000
repurchase of common stock
proceeds from exercise of stock options	10,100,000	2,500,000	500,000	800,000	1,100,000	5,800,000	3,900,000	100,000	6,300,000	6,000,000	2,600,000	2,400,000	800,000	1,100,000				1,500,000				6,200,000				9,061,000		2,258,000	8,245,000	2,961,000				6,335,000																																								22,000
proceeds from issuance of common stock under employee stock purchase plan			5,900,000	0			5,100,000	0			4,500,000	0
payment of withholding taxes in connection with vesting of restricted stock units	-1,700,000	-21,200,000	-600,000	-900,000	-1,100,000	-5,000,000	-100,000	-200,000	-1,500,000	-11,400,000	-100,000	-200,000	-1,200,000	-15,300,000	-600,000	-300,000	-1,200,000	-26,100,000	-2,900,000	-100,000	-1,600,000	-25,200,000				-7,512,000	-3,935,000	-1,155,000	-875,000	-11,816,000	-238,000	-388,000	-289,000	-3,139,000	-27,000	-229,000	-970,000	-1,640,000	-178,000	-41,000	-993,000	-1,434,000	-92,000	-2,683,000	-2,008,000	-3,882,000	-700,000	-134,000	-1,111,000	-1,320,000	-287,000	-65,000	-207,000	-980,000
net cash from financing activities	-343,600,000	277,800,000	-20,900,000	7,800,000	-900,000	-14,100,000	2,200,000	-6,900,000	3,200,000	-12,100,000	-14,500,000	-3,900,000	-1,600,000	-20,300,000	-1,500,000			-28,400,000	130,100,000	10,500,000	483,900,000	-19,000,000	-202,445,000	258,198,000	16,198,000	1,549,000	-1,584,000	1,091,000	698,000	-8,870,000	297,897,000	2,456,000	1,267,000	2,927,000	-991,000	182,150,000	-2,408,000	-2,184,000	-663,000	-956,000	-1,001,000	2,249,000	2,847,000	-30,887,000	33,011,000	-939,000	2,130,000	1,089,000	133,000	93,041,000	1,498,000	1,435,000	802,000	-347,000	87,000	1,180,000	51,858,000	1,977,000	19,976,000	357,000	6,509,000	610,000	66,332,000	32,546,000	281,000	24,637,000	111,000	66,000	56,719,000	-2,163,000	8,332,000	-10,000	113,455,000	41,000
effect of exchange rate changes on cash and cash equivalents	8,900,000	3,800,000		4,600,000	-900,000	-2,500,000
net increase in cash, cash equivalents and restricted cash	-161,500,000	329,700,000		81,600,000	69,800,000	47,000,000										2,000,000				59,000,000	577,700,000	-12,300,000		300,015,000	-9,387,000	15,348,000
cash and cash equivalents at beginning of period	0	953,400,000
cash and cash equivalents at end of period	-161,500,000	1,283,100,000
supplemental noncash information:
purchases of property and equipment included in accounts payable and accrued expenses	1,000,000	3,500,000						2,200,000	500,000	5,100,000		1,100,000	-2,900,000	7,800,000		-2,400,000	1,500,000	4,100,000		200,000	-3,900,000	8,400,000		7,565,000
purchases of property, plant and equipment included in long-term debt	1,100,000	2,400,000						5,900,000
unrealized gain on investments			0
cash paid for investments			-12,000,000				0	-200,000	-5,000,000	-2,000,000	0	0
acquisition of other intangible assets
acquisition of a business							0	0	0	-3,000,000
proceeds from issuance of term loan, net of issuance costs			0
repayment of term loan			-1,200,000	-133,500,000	-1,200,000	-1,300,000	-1,200,000	-1,300,000	-1,200,000	-1,300,000	-1,300,000	-1,200,000	-1,200,000	-1,300,000
effect of exchange rate changes on cash							3,000,000			-100,000	4,800,000	-5,600,000	-2,900,000	-600,000	-1,600,000	-2,200,000	-1,400,000	-300,000	6,100,000	1,600,000	200,000	-3,100,000	3,332,000	-1,562,000	-82,000	-188,000	-727,000	-13,000	-354,000	-307,000	-41,000	230,000	199,000	58,000	-124,000	-47,000	-5,000	210,000	-55,000
net increase in cash, cash equivalents, and restricted cash
cash, cash equivalents, and restricted cash, beginning of year
cash, cash equivalents, and restricted cash, end of year
supplemental cash flow information
acquisition of intangible assets								0	0	-25,100,000	-11,100,000	-2,800,000	-4,500,000	-3,100,000	-5,100,000	-1,900,000	-3,300,000	-500,000	-29,200,000	-7,800,000	0	-500,000	-810,000	-1,425,000
repayment of financing lease				-100,000	-100,000	-5,800,000
cash, cash equivalents and restricted cash at beginning of period				0	0	704,200,000		0	0	689,700,000		0	0	806,400,000		0	0	922,000,000		0	0	213,700,000		0
cash, cash equivalents and restricted cash at end of period				81,600,000	69,800,000	751,200,000		25,300,000	24,200,000	635,900,000		13,300,000	-1,100,000	724,900,000		2,000,000	33,900,000	835,500,000		59,000,000	577,700,000	201,400,000		300,015,000
loss on extinguishment of convertible debt
receipts from the maturity or sale of marketable securities
proceeds from equipment financings
payment of debt issuance costs															0	0
prepayments of financing lease obligation
net decrease in cash, cash equivalents and restricted cash								25,300,000	24,200,000	-53,800,000		13,300,000	-1,100,000	-81,500,000				-86,500,000										-9,683,000
purchases of developed software included in accounts payable and accrued expenses								300,000	-400,000	800,000
operating lease liabilities arising from obtaining right-of-use assets
finance lease liability arising from obtaining right-of-use assets
lease liabilities arising from obtaining right-of-use assets									4,900,000	100,000		100,000	10,400,000	1,600,000	200,000			500,000
cash paid for marketable securities
proceeds from mortgage, net of issuance costs
proceeds from issuance of common stock																																										4,876,000									1,785,000	1,500,000
acquisition												0	0	-26,000,000
proceeds from issuance of convertible debt, net of issuance costs
proceeds from equipment financing
purchases of intangible assets included in accounts payable and accrued expenses												-1,600,000	-400,000	2,800,000	-4,100,000	3,800,000	2,100,000	1,400,000
cash paid for investment														-5,000,000
non-cash interest																		11,800,000	11,600,000	11,300,000	11,200,000	11,100,000															2,008,000	1,984,000
stock-based compensation																			15,600,000	6,600,000	5,800,000	7,900,000
proceeds from the maturity or sale of investments
purchases of investments																			0	0	100,000	-38,000,000	-86,696,000	-24,839,000	-36,909,000	-2,156,000	-45,849,000	-27,635,000	-57,060,000	-60,880,000	-182,909,000	-21,673,000
proceeds from equipment financings, net of issuance costs
purchase of capped call options																							-40,000
cash paid for interest, net of amount capitalized
cash paid for taxes
purchases of property, plant and equipment included in accounts payable and accrued expenses
receipts from the maturity or sale of investments																17,000,000	11,800,000	10,700,000	18,400,000	29,300,000	91,900,000	78,800,000	82,625,000	61,089,000	49,155,000	55,031,000	39,859,000	38,641,000	50,508,000	40,266,000	63,010,000	33,199,000
proceeds from issuance of debt																0
repayment of debt																																																0
proceeds from issuance of common stock, net of issuance costs																			0	0
proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan																4,400,000			6,900,000	10,600,000			7,955,000	17,255,000
proceeds from mortgage, net of issuance cost
proceeds from issuance of convertible debt, net of issuance cost
accounts payable, accrued expenses and other current liabilities																				50,000,000	6,500,000	-20,400,000	38,750,000	1,199,000	1,507,000	-5,256,000	18,249,000	20,811,000	3,077,000	-20,950,000	16,811,000	17,910,000	6,818,000	-14,226,000	1,271,000	465,000	7,679,000	-8,776,000	6,204,000	6,785,000	5,056,000	-59,000	-3,336,000	-500,000	3,444,000	917,000	-6,297,000	13,417,000
other liabilities																				0	-1,100,000	-1,300,000		4,030,000
proceeds from issuance of convertible notes, net of issuance costs																																			-179,000
supplemental cash flow information:
benefit from bad debts																							1,856,000	675,000	1,162,000	807,000	794,000	1,002,000	889,000	697,000	420,000	780,000	427,000	295,000	181,000	815,000	419,000	655,000	-1,578,000	1,582,000	852,000	328,000	585,000	865,000	913,000	891,000	799,000	1,374,000	1,241,000	1,327,000	1,088,000	835,000	587,000	899,000	1,465,000	894,000	439,000	367,000	798,000	834,000	602,000	1,083,000	2,200,000	1,150,000	432,000	1,238,000	2,252,000	890,000	550,000	572,000	438,000	293,000	269,000	120,000
accounts and unbilled receivable
deferred revenue																							1,153,000	657,000	179,000	11,000	-1,026,000	-135,000	-461,000	-2,165,000	524,000	493,000	131,000	-87,000	133,000	38,000	-138,000	-882,000	106,000	169,000	221,000	313,000	720,000	-421,000	643,000	-288,000	333,000	-333,000	-761,000	-3,784,000	4,307,000	-10,000	-1,483,000	49,000	389,000	-1,532,000	1,883,000	-2,405,000													639,000	-52,000	84,000	395,000
other long-term liabilities																										-740,000	2,683,000	168,000	-395,000	627,000	534,000	191,000	366,000	111,000	44,000	-9,000	-191,000	956,000	814,000	223,000	-117,000	264,000	194,000	1,059,000	-463,000	41,000	-624,000	321,000	60,000	319,000	-203,000	2,000	28,000	-12,000
principal payments of capital lease obligations																															0	0	0	-269,000	-791,000	-1,255,000	-2,132,000	-1,340,000	-1,293,000	-1,469,000	-1,621,000	-1,193,000	-1,684,000	-912,000	-644,000	-618,000
net increase in cash and cash equivalents																																			-78,228,000								4,821,000	-29,173,000	29,931,000	-4,113,000	-4,178,000	2,961,000	2,879,000	90,772,000									9,356,000			-9,658,000	55,302,000	20,332,000	-15,802,000	11,501,000	-17,471,000				-9,625,000	-15,605,000	100,742,000	-14,155,000
cash and cash equivalents, beginning of year																																																																							0	0
cash and cash equivalents, end of year
loss on extinguishment of long-term debt																																			0
accounts receivable and unbilled receivable																								-551,000	-2,610,000	-2,796,000		-17,364,000	-9,017,000	1,800,000
payments for taxes related to net share settlement of equity awards																								-291,000
additions to rou assets resulting from new operating lease liabilities
adjustments to reconcile net income to net cash from operating activities
purchases of property, equipment
non-cash investing and financing activities:
purchases of property, equipment and intangible assets																										-45,255,000	-34,795,000
cash, cash equivalents and restricted cash, beginning of period																										113,906,000		0
cash, cash equivalents and restricted cash, end of period																										129,254,000		-9,683,000
impairments and other
proceeds from divestiture of business																																			0	0	1,100,000	4,614,000
repayment of convertible notes																													-6,672,000	-15,000					0
cash, cash equivalents and restricted cash, beginning of year
cash, cash equivalents and restricted cash, end of year
supplemental disclosure of cash flow information
non-cash investing and financing activities
allocation to equity for conversion feature for issuance of 1.375% convertible notes
allocation to equity for conversion feature for issuance of 1.25% convertible notes
allocation to equity for conversion feature for the repurchase of 2% convertible notes
purchases of property, equipment and software																													-54,563,000	-35,374,000	-29,413,000	-8,745,000	-13,389,000	-25,679,000
net decrease in cash and cash equivalents																														-69,431,000			-2,550,000	-61,136,000			-35,974,000	-11,037,000				-5,585,000									-6,150,000	-6,701,000	-12,862,000	-10,949,000		-2,934,000	2,258,000	-8,786,000											26,073,000	-21,553,000
cash, cash equivalents, beginning of period																														272,577,000
cash, cash equivalents, end of period																														203,146,000
acquisition of business
cash paid for interest																																																							2,889,000	0			3,729,000	696,000	2,981,000	681,000	2,746,000	1,195,000			2,272,000	0	1,038,000	708,000	786,000	896,000
purchases of property and equipment under capital lease																																							0	0	0	5,721,000	0				0	4,737,000
non-cash interest and other income																																4,118,000	4,073,000	3,994,000					1,957,000	1,932,000	1,906,000	1,883,000	1,856,000	2,528,000	3,341,000	2,528,000	1,330,000	2,593,000
proceeds from exercise of stock options and issuance of common stock																																2,844,000
cash and cash equivalents, beginning of period																																0	0	137,174,000	0	0	0	122,672,000	0	0	0	151,193,000		0	0	149,727,000		0	0	57,293,000		0	0	93,955,000		0	0	113,274,000		0	0	127,996,000		0	0	56,663,000		0	0	94,588,000				33,231,000
cash and cash equivalents, end of period																																28,745,000	-2,550,000	76,038,000	-78,228,000	139,741,000	-35,974,000	111,635,000	-22,795,000	330,000	-471,000	145,608,000		-29,173,000	29,931,000	145,614,000		2,961,000	2,879,000	148,065,000		-6,701,000	-12,862,000	83,006,000		-2,934,000	2,258,000	104,488,000		-14,153,000	-267,000	118,338,000		20,332,000	-15,802,000	68,164,000	-17,471,000	-24,974,000	26,073,000	73,035,000	-9,625,000	-15,605,000	100,742,000	19,076,000
purchases of short-term investments																																		-41,347,000	-101,413,000	-40,644,000
receipts from the maturity or sale of short-term investments																																		24,740,000
impairment and other charges																																															0
purchases of property and equipment																																			-2,910,000	-13,300,000	-2,745,000	-3,160,000	-3,482,000	-2,525,000	-255,000	-4,346,000	-2,633,000	-3,108,000	-3,588,000	-2,157,000	-2,790,000	-1,822,000	-1,626,000	-1,069,000	-2,055,000	-4,687,000	-2,550,000	-1,699,000	-2,276,000	-3,278,000	-2,663,000	-2,897,000	-2,917,000	-1,646,000	-896,000	-1,090,000	-1,172,000	-1,212,000	-591,000	-165,000	-606,000	-1,617,000	-2,545,000	-5,279,000	-1,749,000	-2,830,000	-3,179,000	-2,331,000
acquisition of canadian distribution business																																							0
proceeds from issuance of common stock, net of offering costs																																			6,000	3,358,000	694,000	796,000	808,000	554,000			4,709,000	1,538,000	1,778,000	3,561,000
allocation to equity for conversion feature for issuance of 2% convertible notes
common stock issued in exchange for 3.75% convertible notes
receipts from the sale of short-term investments
allocation to equity for conversion feature for issuance of convertible notes
allocation to equity for conversion feature for the repurchase of convertible notes
proceeds from issuance of long-term debt, net of issuance costs																																											-86,000	6,000											-80,000	-74,000
repayment of long-term debt																																											0	-28,836,000
allocation to equity for conversion feature for the 2% notes																																											0	0
common stock issued in exchange for 3.75% convertible senior notes
net cash provided operating activities
net (decrease) in cash and cash equivalents
non-cash financing activities
common stock issued in exchange for senior convertible notes
common stock issued in exchange for 5.375% convertible senior notes																																															0	0
deferred tax provision
acquisition of neighborhood diabetes																																																							0	0
principal payment of long-term debt
issuance of common stock for the acquisition of neighborhood diabetes																																																							0	0
payments for capital lease obligations
net proceeds from issuance of common stock																																																1,559,000	3,244,000	94,361,000
accounts payable, accrued expenses, and other liabilities																																																		-1,826,000	-5,658,000	5,927,000	-1,806,000	4,536,000	2,845,000	-318,000
restructuring and impairment of assets
proceeds from issuance of long-term debt
payment of transaction fees related to the credit facility amendment
payments to retire long-term debt																																																								0
proceeds from exercise of warrants
proceeds from issuance of common stock, net of offering expenses																																																						633,000	167,000	1,254,000	1,116,000	1,977,000		357,000	6,977,000	610,000		27,544,000	281,000	124,000	159,000	149,000	550,000	555,000	11,049,000	-10,000
amortization of debt discount																																																							2,220,000	2,142,000	1,425,000	1,424,000	7,754,000	1,887,000	2,386,000	1,238,000	1,077,000	7,823,000	1,633,000	1,039,000	0	0	538,000	58,000	60,000	60,000	59,000	60,000
principal payments of long term debt																																																																						-2,727,000
allocation of fair value of warrants from net proceeds from issuance of facility agreement																																																															0	0	0	6,065,000
non cash interest expense																																																								146,000	2,114,000	121,000	1,125,000	214,000	308,000	132,000	130,000	1,438,000			178,000	172,000			0	0	0	-57,000
impairment of assets
prepaid expenses and other current assets																																																								1,285,000	496,000	-930,000
other long term liabilities																																																								-43,000	-189,000	-127,000	-109,000	-229,000	-7,000	-35,000	-1,000	-216,000	-237,000	172,000	126,000	113,000	102,000	2,115,000	103,000	94,000	917,000	1,000
payment of transaction fees related to credit facility amendment
depreciation																																																										1,163,000	1,131,000	1,250,000	1,258,000	1,438,000	1,221,000	1,370,000	1,325,000	1,306,000	1,710,000	1,781,000	1,526,000	1,358,000		1,333,000	1,173,000	846,000
accounts payable and accrued expenses																																																										-287,000	-1,912,000	-2,325,000	5,535,000	-2,437,000	1,273,000	1,071,000	-3,572,000	2,715,000	281,000	-301,000	-84,000	4,929,000	1,089,000	-420,000	-673,000	1,369,000
unissued restricted stock units																																																										-538,000
stock based compensation expense
other assets																																																											-1,000								-8,000	0	-41,000	50,000	69,000	68,000	1,129,000	-1,675,000
net proceeds from issuance of debt
proceeds from payment of subscription receivable																																																																			0	0	0	9,000				19,000
stock compensation expense																																																												1,272,000	1,374,000	1,311,000	1,017,000	954,000	1,030,000	1,201,000	750,000	960,000	984,000	674,000	581,000	432,000	298,000	209,000
non cash impairment charges
inventory																																																														3,486,000	-1,852,000	1,234,000	4,738,000	1,723,000	-403,000	-3,131,000	-5,830,000	484,000	-3,418,000	-443,000	127,000	-866,000
prepaids and other current assets																																																														-769,000	-767,000	536,000	1,284,000	-357,000	493,000	-773,000	95,000	-1,452,000	372,000	-515,000	549,000	30,000
deferred revenue, short term																																																												-992,000				361,000				590,000	344,000	-13,000
net proceeds from facility agreement
repayment of long term loan
proceeds from issuance of facility agreement, net of financing expenses																																																																32,502,000	0	24,513,000
deferred revenue, short-term																																																														557,000				107,000
redeemable convertible preferred stock warrant expense																																																																							0	0	-10,000	84,000
redemption of long term loan																																																																				0
conversion of preferred stock to common stock upon initial public offering																																																																							0	0
principal payments of long term loan																																																																				0
proceeds from convertible note offering, net of financing expenses
principal payments of long-term loan
decrease in restricted cash
proceeds from sale of series e preferred stock, net of issuance cost
accretion of redeemable convertible preferred stock
loss on impairment and disposal of assets
net proceeds from convertible note offering																																																																				-83,000
adjustments to reconcile net income to net cash from operating activities depreciation
decrease (increase) in restricted cash
principal payments under capital lease
gain/ loss on disposal of assets
loss on impairment of assets

We provide you with 20 years of cash flow statements for Insulet stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Insulet stock. Explore the full financial landscape of Insulet stock with our expertly curated income statements.

The information provided in this report about Insulet stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.